FCVAX | VISVX | FCVAX / VISVX | |
Total Expense Ratio | 1.26 | 0.19 | 663% |
Annual Report Gross Expense Ratio | 1.26 | 0.19 | 663% |
Fund Existence | 21 years | 27 years | - |
Gain YTD | -0.495 | 5.707 | -9% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 4.58B | 59.1B | 8% |
Annual Yield % from dividends | 0.61 | 1.88 | 33% |
Returns for 1 year | -1.20 | 6.07 | -20% |
Returns for 3 years | 22.83 | 43.26 | 53% |
Returns for 5 years | 48.70 | 78.02 | 62% |
Returns for 10 years | 16.44 | 111.90 | 15% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
CBLS | 29.13 | 0.51 | +1.79% |
Clough Hedged Equity ETF | |||
SEIM | 45.52 | 0.38 | +0.84% |
SEI Enhanced US Large Cap Momt Fac ETF | |||
IEMG | 67.23 | 0.50 | +0.75% |
iShares Core MSCI Emerging Markets ETF | |||
KAUG | 26.19 | 0.11 | +0.44% |
Innovator U.S. Small Cp Pwr Buf ETF -Aug | |||
DHY | 2.08 | -0.01 | -0.48% |
Credit Suisse High Yield |